Frankfurt - Delayed Quote EUR
Intellia Therapeutics, Inc. (38I.F)
6.98
+0.28
+(4.18%)
At close: April 25 at 3:49:30 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
1,191,015
1,300,977
1,520,114
1,294,464
Total Liabilities Net Minority Interest
319,059
250,808
284,530
254,220
Total Equity Gross Minority Interest
871,956
1,050,169
1,235,584
1,040,244
Total Capitalization
871,956
1,050,169
1,235,584
1,040,244
Common Stock Equity
871,956
1,050,169
1,235,584
1,040,244
Capital Lease Obligations
210,198
115,346
130,703
74,023
Net Tangible Assets
871,956
1,050,169
1,235,584
1,040,244
Working Capital
529,012
883,122
1,090,243
643,470
Invested Capital
871,956
1,050,169
1,235,584
1,040,244
Tangible Book Value
871,956
1,050,169
1,235,584
1,040,244
Total Debt
210,198
115,346
130,703
74,023
Share Issued
102,029.59
92,997.16
87,103.01
74,485.88
Ordinary Shares Number
102,029.59
92,997.16
87,103.01
74,485.88
12/31/2021 - 5/12/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
05Y.F Vivoryon Therapeutics N.V.
1.8120
-2.16%
F6T.F Fate Therapeutics, Inc.
1.1715
+2.14%
22UA.F BioNTech SE
87.65
-13.39%
GRCE Grace Therapeutics, Inc.
2.4900
+4.62%
DYN Dyne Therapeutics, Inc.
11.06
-0.45%
TPST Tempest Therapeutics, Inc.
7.76
-3.60%
OCGN Ocugen, Inc.
0.7192
-2.40%
CRSP CRISPR Therapeutics AG
38.27
-2.15%